BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2467846)

  • 1. Treatment of nonmetastatic gestational trophoblastic disease with sequential intramuscular and oral methotrexate.
    Barter JF; Soong SJ; Hatch KD; Orr JW; Partridge EC; Austin JM; Shingleton HM
    Gynecol Oncol; 1989 Apr; 33(1):82-4. PubMed ID: 2467846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
    Homesley HD; Blessing JA; Rettenmaier M; Capizzi RL; Major FJ; Twiggs LB
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):413-8. PubMed ID: 2457192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma methotrexate levels in patients with gestational trophoblastic neoplasia treated by two methotrexate regimens.
    Rotmensch J; Rosenshein N; Donehower R; Dillon M; Villar J
    Am J Obstet Gynecol; 1984 Mar; 148(6):730-4. PubMed ID: 6199978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid.
    Gleeson NC; Finan MA; Fiorica JV; Robert WS; Hoffman MS; Wilson J
    Eur J Gynaecol Oncol; 1993; 14(6):461-5. PubMed ID: 7514124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-agent chemotherapy for nonmetastatic gestational trophoblastic neoplasia. Perspectives for the 21st century after three decades of use.
    Kohorn EI
    J Reprod Med; 1991 Jan; 36(1):49-55. PubMed ID: 1848901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose methotrexate for gestational trophoblastic disease.
    Elit L; Covens A; Osborne R; Gerulath A; Murphy J; Rosen B; Sturgeon J
    Gynecol Oncol; 1994 Sep; 54(3):282-7. PubMed ID: 7522198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of trophoblastic disease].
    Nechaeva ID; SemenovskiÄ­ AV
    Vopr Onkol; 1976; 22(5):85-92. PubMed ID: 180685
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy.
    Roberts JP; Lurain JR
    Am J Obstet Gynecol; 1996 Jun; 174(6):1917-23; discussion 1923-4. PubMed ID: 8678159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group.
    Petrilli ES; Twiggs LB; Blessing JA; Teng NH; Curry S
    Cancer; 1987 Nov; 60(9):2173-6. PubMed ID: 2449942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of nonmetastatic gestational trophoblastic disease: results of methotrexate alone versus methotrexate--folinic acid.
    Smith EB; Weed JC; Tyrey L; Hammond CB
    Am J Obstet Gynecol; 1982 Sep; 144(1):88-92. PubMed ID: 6287843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease.
    Khoo SK; Jones IS
    Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease.
    Rose PG; Piver MS
    J Surg Oncol; 1989 Jul; 41(3):148-52. PubMed ID: 2545973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.
    Hoffman MS; Fiorica JV; Gleeson NC; Roberts WS; Cavanagh D
    Gynecol Oncol; 1996 Feb; 60(2):292-4. PubMed ID: 8631554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of nonmetastatic gestational trophoblastic disease with oral methotrexate.
    Barter JF; Soong SJ; Hatch KD; Orr JW; Partridge EC; Austin JM; Shingleton HM
    Am J Obstet Gynecol; 1987 Nov; 157(5):1166-8. PubMed ID: 2825524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-day methotrexate for women with metastatic gestational trophoblastic disease.
    Soper JT; Clarke-Pearson DL; Berchuck A; Rodriguez G; Hammond CB
    Gynecol Oncol; 1994 Jul; 54(1):76-9. PubMed ID: 8020843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
    Kwon JS; Elit L; Mazurka J; Moens F; Schmuck ML
    Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinomycin D as the primary agent for gestational trophoblastic disease.
    Osathanondh R; Goldstein DP; Pastorfide GB
    Cancer; 1975 Sep; 36(3):863-6. PubMed ID: 171055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of low-risk metastatic gestational trophoblastic tumors.
    DuBeshter B; Berkowitz RS; Goldstein DP; Bernstein MR
    J Reprod Med; 1991 Jan; 36(1):36-9. PubMed ID: 1848898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trophoblastic cell sensitivity to 8-day chemotherapy in nonmetastatic gestational trophoblastic neoplasia.
    Hilgers RD; Standefer JC; Rutledge JM; Ampuero F
    Gynecol Oncol; 1984 Mar; 17(3):386-93. PubMed ID: 6200387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.